Reconstitution and phenotype of tregs in CMV reactivating patients following allogeneic hematopoietic stem cell transplantation

Immunological Investigations

Volumn 42, Issue 1, 2013, Pages 18-35

  Velaga, Sarvari ^a   Ukena, Sya N ^a   Höpting, Matthias ^a   Ivanyi, Philipp ^a   Borchers, Sylvia ^a   Mischak Weissinger, Eva Maria ^a   Hamwi, Iyas ^a   Buchholz, Stefanie ^a   Ganser, Arnold ^a   Franzke, Anke ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

CMV infection; Phenotype; Regulatory T cells; Stem cell transplantation

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; KI 67 ANTIGEN;

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GRAFT VERSUS HOST REACTION; HUMAN; LYMPHOCYTE ACTIVATION; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; VIRUS REACTIVATION;

ADULT; AGED; ANTIGENS, CD; CELL PROLIFERATION; CELLS, CULTURED; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RECEPTORS, CXCR3; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; VIRUS ACTIVATION; YOUNG ADULT;

EID: 84870914877     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2012.719563     Document Type: Article

References (36)

1. Aandahl, E. M., Michaelsson, J., Moretto, W. J., Hecht, F. M., Nixon, D. F. (2004). Human CD4 CD25 regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J. Virol. 78:2454-2459.
2. Boeckh, M., Leisenring, W., Riddell, S. R., et al. (2003). Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: Importance of viral load and T-cell immunity. Blood 101:407-414.
3. Boeckh, M., Bowden, R. (1995). Cytomegalovirus infection in marrow transplantation. Cancer Treat. Res. 76:97-136.
4. Brunstein, C. G., Miller, J. S., Cao, Q., et al. (2011). Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: Pafety profile and detection kinetics. Blood 117:1061-1070.
5. Cabrera, R., Tu, Z., Xu, Y., et al. (2004). An immunomodulatory role for CD4 CD25 regulatory T lymphocytes in hepatitis C virus infection. Hepatology 40:1062-1071.
6. Cohen, J. L., Trenado, A., Vasey, D., Klatzmann, D., Salomon, B. L. (2002). CD4 CD25 immunoregulatory T cells: New therapeutics for graft-versus-host disease. J. Exper. Med. 196:401-406.
7. Dander, E, Li, P. G., Biagi, E., et al. (2008). Characterization of migratory activity and cytokine profile of helper and cytotoxic CMV-specific T-cell lines expanded by a selective peptide library. Exp. Hematol. 36:473-485.
8. di Ianni, M., Falzetti, F., Carotti, A., et al. (2011). Tregs prevent GvHD and promote immune reconstitution inHLA-haploidentical transplantation. Blood. 117:3921-3928.
9. Edinger, M., Hoffmann, P., Ermann, J., et al. (2003). CD4CD25 regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat. Med. 9:1144-1150.
10. Ermann, J., Hoffmann, P., Edinger, M., et al. (2005). Only the CD62L subpopulation of CD4 CD25 regulatory T cells protects from lethal acute GVHD. Blood 105:2220-2226.
11. Hoffmann, P., Ermann, J., Edinger, M., Fathman, C. G., Strober, S. (2002). Donor-type CD4 CD25 regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J. Exp. Med. 196:389-399.
12. Kinter, A. L., Hennessey, M., Bell, A., et al. (2004). CD25 CD4 regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4 and CD8 HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J. Exp. Med. 200:331-343.
13. Mendez, S., Reckling, S. K., Piccirillo, C. A., Sacks, D., Belkaid, Y. (2004). Role for CD4 CD25 regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J. Exp. Med. 200:201-210.
14. Nguyen, V. H., Shashidhar, S., Chang, D. S., et al. (2008). The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation. Blood 111:945-953.
15. Sugimoto, K., Ikeda, F., Stadanlick, J., et al. (2003). Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology 38:1437-1448.
16. Suvas, S., Kumaraguru, U., Pack, C. D., Lee, S., Rouse, B. T. (2003). CD4 CD25 T cells regulate virus-specific primary and memory CD8 T cell responses. J. Exp. Med. 198:889-901.
17. MacDonald, A. J., Duffy, M., Brady, M. T., et al. (2002). CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons. J. Infect. Dis. 185:720-727.
18. Mielke, S., Rezvani, K., Savani, B. N., et al. (2007). Reconstitution of FOXP3 regulatory T cells (T-regs) after CD25-depleted allotransplantion in elderly patients and association with acute graft-versus-host disease. Blood 110:1689-1697.
19. Ngoma, A. M., Ikeda, K., Hashimoto, Y., et al. (2012). Impaired regulatory T cell reconstitution in patients with acute graft-versus-host disease and cytomegalovirus infection after allogeneic bone marrow transplantation. Int. J. Hematol. 95:86-94.
20. Olive, A. J., Gondek, D. C., Starnbach, M. N. (2011). CXCR3 and CCR5 are both required for T cell-mediated protection against C. trachomatis infection in the murine genital mucosa. Mucosal Immunol. 4:208-216.
21. Ozdemir, E., St John, L. S., Gillespie, G., et al. (2002). Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8 T cells. Blood 100:3690-3697.
22. Przepiorka, D., Anderlini, P., Saliba, R., et al. (2011). Chronic graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 98:1695-1700.
23. Przepiorka, D., Smith, T. L., Folloder, J., et al. (1999). Risk factors for acute graft-versushost disease after allogeneic blood stem cell transplantation. Blood 94:1465-1470.
24. Przepiorka, D., Weisdorf, D., Martin, P., et al. (1995). Consensus Conference on Acute Gvhd Grading. Bone Marrow Transplant. 15:825-828.
25. Rezvani, K., Mielke, S., Kilical, Y., et al. (2005). Inverse correlation of early regulatory T cell reconstitution post-transplant and acute and chronic graft-versus-host-disease. Blood 106:409A.
26. Ridge, J. P., Di, R. F., Matzinger, P. (1998). A conditioned dendritic cell can be a temporal bridge between a CD4 T-helper and a T-killer cell. Nature 393:474-478.
27. Rieger, K., Loddenkemper, C., Maul, J., et al. (2005). Mucosal Foxp3 regulatory T cells show significant numerical differences in patients with intestinal graft-versus-host disease compared to infectious diseases of the gut. Blood 106:177A.
28. Schoenberger, S. P., Toes, R. E., van der Voort, E. I., Offringa, R., Melief, C. J. (1998). Tcell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480-483.
29. Schwele, S., Fischer, A. M., Brestrich, G., et al. (2012). Cytomegalovirus-specific regulatory and effector T cells share TCR clonalityYpossible relation to repetitive CMV infections. Am. J. Transplant. 12:669-681.
30. Taylor, P. A., Lees, C. J., Blazar, B. R. (2002). The infusion of ex vivo activated and expanded CD4 CD25 immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99:3493-3499.
31. Taylor, P. A., Panoskaltsis-Mortari, A., Swedin, J. M., et al. (2004). L-Selectin(hi) but not the L-selectin(lo) CD4 25 T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood 104:3804-3812.
32. Trenado, A., Charlotte, F., Fisson, S., et al. (2003). Recipient-type specific CD4 CD25 regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J. Clin. Invest. 112:1688-1696.
33. Ukena, S. N., Grosse, J., Mischak-Weissinger, E., et al. (2011a). Acute but not chronic graft-versus-host disease is associated with a reduction of circulating CD4 CD25 (high)CD127 (low/-) regulatory T cells. Ann. Hematol. 90:213-218.
34. Ukena, S. N., Velaga, S., Geffers, R., et al. (2011b). Human regulatory T cells in allogeneic stem cell transplantation. Blood 118:e82Ye92.
35. Ukena, S. N., Hopting, M., Velaga, S., et al. (2011c). Isolation strategies of regulatory T cells for clinical trials: Phenotype, function, stability, and expansion capacity. Exp. Hematol. 39:1152-1160.
36. Widmann, T., Sester, U., Gartner, B. C., et al. (2008). Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation. PLoS One 3:e3634.